Published in J Cardiovasc Pharmacol on November 01, 1997
Adrenomedullin and diabetes. World J Diabetes (2014) 0.77
The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med (1992) 3.53
Atrial natriuretic peptide elevation in congestive heart failure in the human. Science (1986) 3.37
Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet (1993) 3.34
Modulation of vascular smooth muscle contraction by the endothelium. Annu Rev Physiol (1986) 2.76
Genomic organization of Borna disease virus. Proc Natl Acad Sci U S A (1994) 2.74
Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension (1996) 2.37
KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric (2005) 2.32
Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med (1991) 2.22
Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation (1998) 2.08
Risk factors for epistaxis during nasotracheal intubation. Anaesth Intensive Care (2002) 2.04
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res (1993) 1.98
Atrial natriuretic peptide and blood pressure in a population-based sample. Mayo Clin Proc (1995) 1.98
Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke (2000) 1.83
Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer (2003) 1.80
Natriuretic peptide system in human heart failure. Circulation (1993) 1.79
Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol (1984) 1.71
Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res (2004) 1.71
Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc (1992) 1.70
Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study. Heart (2009) 1.69
The effect of combining dexamethasone with ondansetron for nausea and vomiting associated with fentanyl-based intravenous patient-controlled analgesia. Anaesthesia (2011) 1.69
The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med (1998) 1.60
Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res (1988) 1.58
Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther (1988) 1.57
Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. Circulation (1990) 1.57
Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest (1989) 1.57
Endothelin in human congestive heart failure. Circulation (1994) 1.56
Production of cellulases and hemicellulases by Aspergillus niger KK2 from lignocellulosic biomass. Bioresour Technol (2004) 1.56
Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation (1995) 1.55
Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol (1990) 1.55
Lack of association between vitamin D receptor genotypes and osteoporosis in Koreans. J Clin Endocrinol Metab (1995) 1.54
Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain. Mayo Clin Proc (1998) 1.53
Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure. J Clin Invest (1988) 1.53
In vitro evaluation of endothelial and smooth muscle function of primary varicose veins. J Vasc Surg (1992) 1.51
Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol (1992) 1.50
Effects of bed height on the performance of chest compressions. Emerg Med J (2009) 1.47
Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma. Ann Oncol (2007) 1.46
Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice. Am J Physiol Heart Circ Physiol (2001) 1.44
Expression of atrial natriuretic factor in the human ventricle is independent of chamber dilation. J Am Coll Cardiol (1990) 1.41
Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol (1992) 1.41
A feminist critique of research on menopausal experience of Korean women. Res Nurs Health (1999) 1.40
Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines. Vaccine (1999) 1.33
Endothelial alpha 2-adrenoceptors in canine pulmonary and systemic blood vessels. Eur J Pharmacol (1985) 1.33
Risk factors for the development of NIDDM in Yonchon County, Korea. Diabetes Care (1997) 1.33
Unique activity associated with non-insecticidal Bacillus thuringiensis parasporal inclusions: in vitro cell-killing action on human cancer cells. J Appl Microbiol (1999) 1.32
Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol (1998) 1.32
Renal interstitial pressure and sodium excretion during renal vein constriction. Am J Physiol (1980) 1.31
The compartment syndrome. An experimental and clinical study of muscular energy metabolism using phosphorus nuclear magnetic resonance spectroscopy. Clin Orthop Relat Res (1988) 1.29
Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc (2001) 1.29
Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol (2000) 1.28
Optimizing tourniquet application and release times in extremity surgery. A biochemical and ultrastructural study. J Bone Joint Surg Am (1985) 1.27
Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol (1992) 1.27
Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol (1993) 1.26
Comparison of the GlideScope video laryngoscope and Macintosh laryngoscope in simulated tracheal intubation scenarios. Emerg Med J (2008) 1.26
Adenylate kinase-catalyzed phosphotransfer in the myocardium : increased contribution in heart failure. Circ Res (1999) 1.24
Failing energetics in failing hearts. Curr Cardiol Rep (2000) 1.24
Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol (1992) 1.23
Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? Circulation (2001) 1.23
Enzyme-linked immunosorbent assay for detecting antibodies to Borna disease virus-specific proteins. J Clin Microbiol (1995) 1.22
Adrenomedullin: potential in physiology and pathophysiology. Life Sci (2000) 1.22
The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Proc Assoc Am Physicians (1999) 1.20
A prototypical cytidylyltransferase: CTP:glycerol-3-phosphate cytidylyltransferase from bacillus subtilis. Structure (1999) 1.19
C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol (1993) 1.19
Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation (1995) 1.18
Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum. Br J Cancer (2012) 1.17
Heterogeneity of endothelium-dependent responses in mammalian blood vessels. J Cardiovasc Pharmacol (1985) 1.16
Spontaneous acute tumor lysis syndrome with advanced gastric cancer. J Korean Med Sci (2001) 1.16
Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure. Kidney Int (1996) 1.15
Parasporin, a human leukemic cell-recognizing parasporal protein of Bacillus thuringiensis. Clin Diagn Lab Immunol (2000) 1.15
Thermosoftening treatment of the nasotracheal tube before intubation can reduce epistaxis and nasal damage. Anesth Analg (2000) 1.14
Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens (2000) 1.12
Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study. Epidemiol Infect (2012) 1.11
Modulation of endothelium-dependent responses by chronic alterations of blood flow. Am J Physiol (1986) 1.09
Identification of the genes encoding enzymes involved in the early biosynthetic pathway of pteridines in Synechocystis sp. PCC 6803. FEMS Microbiol Lett (1999) 1.09
A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study. Am Heart J (1999) 1.09
Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease. Aliment Pharmacol Ther (2009) 1.09
Construction of a BAC library of Korean ginseng and initial analysis of BAC-end sequences. Mol Genet Genomics (2004) 1.08
Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail (2000) 1.07
Mortality risk factors of Acinetobacter baumannii bacteraemia. Intern Med J (2005) 1.07
Spatial correlates of hippocampal unit activity are altered by lesions of the fornix and endorhinal cortex. Brain Res (1980) 1.07
Natriuretic peptides in the pathophysiology of congestive heart failure. Curr Cardiol Rep (2000) 1.06
Diagnostic accuracy of Xpert® MTB/RIF on bronchoscopy specimens in patients with suspected pulmonary tuberculosis. Int J Tuberc Lung Dis (2013) 1.06
Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron. J Int Med Res (2002) 1.05
Processing time, articulation time, and memory span. J Exp Child Psychol (1994) 1.05
Intact and altered endothelium in regulation of vasomotion. Circulation (1992) 1.05
CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-beta signaling. Oncogene (2007) 1.05
Renal actions of synthetic dendroaspis natriuretic peptide. Kidney Int (1999) 1.05
Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure. Hypertension (2001) 1.05
Alpha 2-adrenoceptors and endothelium-derived relaxing factor. Am J Med (1989) 1.04
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum. Br J Cancer (2012) 1.04
A new selection method for pepper transformation: callus-mediated shoot formation. Plant Cell Rep (2004) 1.04
Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries. Am J Physiol (1992) 1.04
Purification and characterization of UDP-glucose:tetrahydrobiopterin glucosyltransferase from Synechococcus sp. PCC 7942. Biochim Biophys Acta (2000) 1.04
Endothelium-dependent contractions to arachidonic acid are mediated by products of cyclooxygenase. Am J Physiol (1985) 1.04
Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. Transplantation (1993) 1.03
C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol (1998) 1.03
Risks for renal dysfunction with cardiac angiography. Ann Intern Med (1986) 1.03
Subcutaneous administration of brain natriuretic peptide in experimental heart failure. J Am Coll Cardiol (2000) 1.02